| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| TRANS-3'-羟基可替宁氘代甲基 | (+/-)-<methyl-d3>-trans-3'-hydroxycotinine | 159956-78-2 | C10H12N2O2 |
| Solcitinib抑制剂 | N-[5-[4-(3,3-dimethylazetidine-1-carbonyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide | 1206163-45-2 | C22H23N5O2 |
| S-(-)-可替宁高氯酸盐 | S-(-)-Cotinine Perchlorate | 1217692-15-3 | C10H13ClN2O5 |
| S-甲基吡啶-3-碳硫亚胺碘化氢盐 | S-Methyl-3-pyridylthioimidate hydroiodide | 1185298-67-2 | C7H9IN2S |
| S-甲基吡啶-2-碳硫亚胺碘化氢盐 | S-Methyl-2-pyridylthioimidate hydroiodide | 96898-29-2 | C7H9IN2S |
| S-甲基6-甲基-2-吡啶基二硫代氨基甲酸酯 | S-methyl 6-methyl-2-pyridinyldithiocarbamate | 106837-78-9 | C8H10N2S2 |
| S-甲基4-甲基-2-吡啶基二硫代氨基甲酸酯 | S-methyl 4-methyl-2-pyridinyldithiocarbamate | 106838-01-1 | C8H10N2S2 |
| S-甲基-S-(2-吡啶基)亚磺酰亚胺 | imino(methyl)(pyridin-2-yl)-λ<sup>6</sup>-sulfanone | 76456-06-9 | C6H8N2OS |
| S-烯丙基-N-甲酰基-DL-半胱氨酸 | 2,5,6-trichloro-3-chloromethylpyridine | 52465-59-5 | C6H3Cl4N |
| S-烟碱-5-甲醛 | nicotine-5-carboxaldehyde | 852238-97-2 | C11H14N2O |
| S-吡啶-2-基硫代羟胺 | 2-pyridylsulfenamide | 3993-58-6 | C5H6N2S |
| S-[2-(4-吡啶基)乙基]硫代乳酸 | S-[2-(4-Pyridyl)ethyl] thiolactic acid | 887407-43-4 | C10H13NO2S |
| S-[(5-羟基-4,6-二甲基-3-吡啶基)甲基]硫代乙酸酯 | 5-(acetylmercapto-methyl)-2,4-dimethyl-pyridin-3-ol | 807263-70-3 | C10H13NO2S |
| S-[(4-氯吡啶-2-基)甲基]硫代磷酸二锂 | Phosphorothioic acid, S-(4-chloro-2-pyridinylmethyl) ester, dilithium salt, monohydrate | 119417-93-5 | C6H5ClLi2NO3PS |
| S-4-羟乙基吡啶 | (S)-1-(4-pyridyl)ethanol | 54656-96-1 | C7H9NO |
| S-(4-甲基苯基)-2-甲基-5-苯基吡啶-3-硫代甲酸酯 | (4-methylphenyl) 2-methyl-5-phenylpyridine-3-carbothioate | 917882-52-1 | C20H17NOS |
| S-(2-甲基-2-丙基)2-吡啶硫代甲酸酯 | S-tert-butyl pyridine-2-carbothioate | 170967-88-1 | C10H13NOS |
| S-(-)-尼古丁二-p-甲苯甲酰-D-酒石酸盐 | l-nicotine di-(p-toluoyl)-l-tartrate | 68935-26-2 | C10H14N2*C20H18O8 |
| S-(-)-尼古丁-吡啶-D4 | (S)-(-)-Nicotine-d4 | 284685-07-0 | C10H14N2 |
| S,S-二甲基-N-(3-吡啶基)亚磺亚胺 | S,S-dimethyl-N-(3-pyridyl)sulfinimine | 156544-61-5 | C7H9ClN2S |
| Rac-可替宁3-羧酸 | rac-Cotinine 3-Carboxylic Acid | 1246815-18-8 | C11H12N2O3 |
| RJR 2403; (E)-位变异烟碱 | (E)-N-methyl-4-(3-pyridinyl)-3-butene-1-amine | 15585-43-0 | C10H14N2 |
| RHPP+离子氯化物 | 4-(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-hydroxybutyl)pyridinium | 154440-77-4 | C21H20ClFNO |
| RAF抑制剂(LY3009120) | LY3009120 | 1454682-72-4 | C23H29FN6O |
| R-(+)-可替宁 | (S)-(-)-1-methyl-5-(3-pyridyl)-2-pyrrolidinone | 32162-64-4 | C10H12N2O |
| Pexacerfont; 8-(6-甲氧基-2-甲基-3-吡啶基)-2,7-二甲基-N-[(1R)-1-甲基丙基]吡唑并[1,5-a]-1,3,5-三嗪-4-胺 | [14C]-Pexacerfont | 459856-18-9 | C18H24N6O |
| PSN375963盐酸盐 | PSN375963 | 388575-52-8 | C17H23N3O |
| PPADS四钠盐 | Ppads | 149017-66-3 | C14H14N3O12PS2 |
| PORCN酶活性和WNT抑制剂(WNT-C59) | 2-(4-(2-methylpyridin-4-yl)phenyl)-N-(4-(pyridin-3-yl)phenyl)acetamide | 1243243-89-1 | C25H21N3O |
| PKD抑制剂(CRT0066101DIHYDROCHLORIDE) | CRT0066101 Dihydrochloride | 1883545-60-5 | C18H24Cl2N6O |
| PI3K伪/MTOR-IN-1 | 2-amino-8-cyclopentyl-6-(1H-pyrazol-4-yl)-4-methylpyrido[2,3-d]pyrimidin-7(8H)-one | 1013098-90-2 | C16H18N6O |
| PHA-543613二盐酸盐 | PHA-543613 Dihydrochloride | 478148-58-2 | C15H19Cl2N3O2 |
| PF-3274167抑制剂 | (5-(3-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-5-(methoxymethyl)-4H-1,2,4-triazol-4-yl)-2-methoxypyridine) | 900510-03-4 | C19H19ClFN5O3 |
| PDK1抑制剂 | ethyl 6-(5-(phenylsulfonamido)pyridin-3-yl)imidazo[1,2-a]-pyridine-3-carboxylate | 1276110-06-5 | C21H18N4O4S |
| PD 173074; N-[2-[[4-(二乙基氨基)丁基]氨基]-6-(3,5-二甲氧基苯基)吡啶并[2,3-d]嘧啶-7-基]-N'-叔丁基脲 | PD 173074 | 219580-11-7 | C28H41N7O3 |
| P,P-二环己基-N,N-二-2-吡啶基亚膦酰胺 | Py2NPCy2 | 472959-98-1 | C22H30N3P |
| P(1),P(2)-二(5'-吡哆醛)二磷酸酯 | Bis[(4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl] dihydrogen diphosphate | 67279-83-8 | C16H18N2O11P2 |
| OTSSP167盐酸盐 | OTSSP167 hydrochloride | 1431698-10-0 | C25H29Cl3N4O2 |
| ORL1拮抗剂1 | ORL1 antagonist 1 | 1174985-59-1 | C20H22ClN5 |
| O5-甲基O3-(2,2,2-三氟乙基)4-(2-氯苯基)-2,6-二甲基-1,4-二氢吡啶-3,5-二羧酸酯 | Methyl 2,2,2-trifluoroethyl 4-(2-chlorophenyl)-1,4-dihydro-2,6-dimethylpyridine-3,5-dicarboxylate | 74687-14-2 | C18H17ClF3NO4 |
| O5-乙基O3-(2-哌啶-1-基乙基)2,6-二甲基-4-(3-硝基苯基)-1,4-二氢吡啶-3,5-二羧酸酯 | Diperdipine | 108852-42-2 | C24H31N3O6 |
| O3-乙基O5-甲基2-(咪唑-1-基甲基)-6-甲基-4-(3-硝基苯基)-1,4-二氢吡啶-3,5-二羧酸酯 | WY 27569 | 103417-69-2 | C21H22N4O6 |
| O3-乙基O5-甲基2-(2-氨基乙基硫基甲基)-6-甲基-4-(3-硝基苯基)-1,4-二氢吡啶-3,5-二羧酸酯 | 2-(2-aminoethylthio)methyl-3-ethoxycarbonyl-5-methoxycarbonyl-4-(m-nitrophenyl)-6-methyl-1,4-dihydropyridine | 110646-15-6 | C20H25N3O6S |
| O3-[2-(4-甲基苯基)乙基]O5-丙-2-基2,6-二甲基-4-吡啶-2-基-1,4-二氢吡啶-3,5-二羧酸酯 | 3-Isopropyl-5-(4-methylphenethyl)-1,4-dihydro-2,6-dimethyl-4-(2-pyridyl)-3,5-pyridinecarboxylate | 122508-12-7 | C26H30N2O4 |
| O3-(2-羟基-2-甲基丙基)O5-甲基2,6-二甲基-4-(2-硝基苯基)-1,4-二氢吡啶-3,5-二羧酸酯 | 4-Hydroxy Nisoldipine | 106685-70-5 | C20H24N2O7 |
| O-吡啶-2-甲基羟胺 | O-(pyridin-2-ylmethyl)hydroxylamine | 37756-48-2 | C6H8N2O |
| O-去甲基非洛地平 | 1,4-Dihydro-2,6-dimethyl-5-ethoxycarbonyl-4-(2,3-dichlorophenyl)-3-pyridinecarboxylic acid | 150131-21-8 | C17H17Cl2NO4 |
| O-去[2-氨基乙基]-O-羧甲基-去氢氨氯地平 | 4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-2-(carboxymethoxy)methyl-6-methylpyridine | 113994-45-9 | C20H20ClNO7 |
| O-丙基2-吡啶基硫代氨基甲酸酯 | Carbamothioic acid, 2-pyridinyl-, O-propyl ester (9CI) | 129196-41-4 | C9H12N2OS |
| O-4-吡啶基硫代乙酸酯 | O-pyridin-4-yl ethanethioate | 180308-29-6 | C7H7NOS |